(10-08-2021, 10:12 PM)bankerboy Wrote: I find it interesting about discussions buying T and BMY. They both seem to have downside risk at this point, T in a big dividend cut and BMY is losing money with bad news from what I can tell.BMY has been digesting a large merger and paying off some debt. To my knowledge they haven't lost any money. CFRA has earnings growth projected at 10% avg annual over the next three years. We'll see if that is going to be adjusted down. Definitely back to trading sideways with the recent dip. Most large CAP pharma is though so it's hard to process how much is just out of favor sector symptoms. MRK-PFE and even JNJ are pretty weak on a three year look back. PFE had their moment but back to sideways. There are others just as flat. LLY may be the exception. I would have great confidence holding BMY through 8-10% growth. Sub 5% and we are back to a PFE or MRK long-term chart.
Interested in the thought behind buying these stocks. Yes the dividend is OK but values seem to be sideways for years.
Sent from my iPhone using Tapatalk
T maybe needs to be more transparent? I'm not sure details are known for the spin off yet but it is still about 3-4 quarters away I think. We suspected the stock would bleed off after the initial announcement and it has. I'm pretty sure the total return is negative for most any look back period over 10yrs. We throw the term "yield trap" around here. T has been a trap by definition. Maybe that is about to change but it's hard to assess.